Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies, Note Payable (Details)

v3.23.3
Commitments and Contingencies, Note Payable (Details)
3 Months Ended
Aug. 16, 2023
USD ($)
Jul. 13, 2023
USD ($)
Jul. 12, 2023
USD ($)
Jun. 15, 2023
USD ($)
May 12, 2023
USD ($)
Apr. 13, 2023
USD ($)
Mar. 31, 2023
USD ($)
Installment
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Note Payable [Abstract]                  
Deposits to trust account from related party advances             $ 990,000    
Note payable               $ 660,000 $ 0
APRINOIA Therapeutics Inc. [Member] | Maximum [Member]                  
Note Payable [Abstract]                  
Number of equal installments in connection with related party advance receivables | Installment             5    
APRINOIA Therapeutics Inc. [Member] | Advance Agreement [Member]                  
Note Payable [Abstract]                  
Proceeds from related party advance amount       $ 165,000 $ 165,000 $ 165,000 $ 165,000    
Related party advance receivables, installment amount             165,000    
Note payable             $ 660,000    
APRINOIA Therapeutics Inc. [Member] | Advance Agreement [Member] | Subsequent Event [Member]                  
Note Payable [Abstract]                  
Proceeds from related party advance amount $ 165,000 $ 165,000 $ 165,000